Back to Markets
EIEikon Therapeutics Inc

Eikon Therapeutics Inc

EIKN
Health CareBiotechnology: Biological Products (No Diagnostic Substances)

$10.84

+0.5400 (+5.24%)

As of 05/29/26 EDT · USD

Compare
Low: $7.90Current: $10.84High: $17.40

Key Statistics

Open

$10.38

Day High

$10.88

Day Low

$10.15

Prev. Close

$10.30

VolumeShares traded today.

199.21K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$586.86M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.75

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$17.40

52W LowLowest price over the past 52 weeks.

$7.90

50D MAAverage closing price over the last 50 trading days.

$10.50

200D MAAverage closing price over the last 200 trading days.

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-2.9%

1M

+19.0%

6M

YTD

-27.7%

1Y

-27.7%

About

Roger M. Perlmutter is the former executive vice president of Merck & Co. and former president of Merck Research Laboratories. He is currently CEO of Eikon Therapeutics and a non-executive director of Merck Research Laboratories.

Company Facts

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade EIKN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.